X0306 4 2022-03-09 false 0001636422 Health Catalyst, Inc. HCAT 0001780978 Horstmeier Paul C/O HEALTH CATALYST, INC. 10897 SOUTH RIVER FRONT PARKWAY, #300 SOUTH JORDAN UT 84095 false true false false Chief Operating Officer Common Stock 2022-03-09 4 M false 521.00 15.84 A 196877.00 D Common Stock 2022-03-09 4 M false 4166.00 15.84 A 201043.00 D Common Stock 2022-03-09 4 S false 23008.00 25.298 D 178035.00 D Common Stock 2022-03-09 4 S false 201.00 26.0152 D 177834.00 D Stock Option (Right to Buy) 15.84 2022-03-09 4 M false 4166.00 0.00 D 2029-02-05 Common Stock 4166.00 39569.00 D Stock Option (Right to Buy) 15.84 2022-03-09 4 M false 521.00 0.00 D 2029-02-05 Common Stock 521.00 6248.00 D The sale reported on this Form 4 was made pursuant to a written trading plan adopted by the Reporting Person in accordance with Rule 10b5-1. Represents a weighted average price. These shares were sold by the Reporting Person in multiple transactions at prices ranging from $25.00 to $25.96, inclusive. Represents the weighted average sale price of the shares sold ranging from $26.00 to $26.05 per share, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in Footnotes (2) and (3). 25% of the 186,467 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. 25% of the 25,000 shares underlying the option vested in an annual installment and the remaining balance vested or will vest in equal monthly installments until the option vests in full on February 5, 2023. /s/ Jason Alger, as Attorney-in-Fact 2022-03-11